Mothercare plc
Interim results announcement
Mothercare plc ("Mothercare" "the Company" or "the Group"), the highly trusted British heritage international brand and franchise operator, that connects with the parents of newborn babies and children across multiple product categories, today announces unaudited half year results for the 26-week period to 26 September 2026 ("H1 FY27"). The comparative period was a 26-week period to 27 September 2025 ("H1 FY26").
Key Trading Highlights
Our Group
|
|
|
|
|
|
|
|
26 weeks to |
26 weeks to |
26 weeks to |
26 weeks to |
|
|
26 Sep 2026 |
27 Sep 2025 |
28 Sep 2024 |
23 Sep 2023 |
|
|
|
|
|
|
|
Turnover £m |
9.3 |
11.6 |
21.0 |
29.0 |
|
Adjusted EBITDA2 £m |
0.5 |
0.8 |
1.7 |
3.6 |
|
Adjusted (loss)/profit from operations 2 £m |
(0.3) |
(0.5) |
1.1 |
3.4 |
|
Adjusted (loss)/profit before taxation2 £m |
(2.2) |
(1.1) |
(1.4) |
1.8 |
|
(Loss)/profit for the period £m
|
(0.2) |
(1.7) |
(1.8) |
1.7 |
|
Adjusted basic (loss)/earnings per share2 |
(0.4)p |
(0.3)p |
(0.3)p |
0.2p |
|
Basic (loss)/ earnings per share |
(0.0)p |
(0.3)p |
(0.3)p |
0.3p |
Our Franchise partners
|
|
|
|
|
|
|
|
26 weeks to |
26 weeks to |
26 weeks to |
26 weeks to |
|
|
26 Sep 2026 |
27 Sep 2025 |
28 Sep 2024 |
23 Sep 2023 |
|
|
|
|
|
|
|
Worldwide retail sales1 £m |
78.1 |
90.7 |
121.2 |
137.2 |
|
Online retail sales £m |
9.3 |
10.0 |
12.2 |
13.7 |
|
|
|
|
|
|
|
Total number of stores |
348 |
344 |
440 |
500 |
|
Space (k) sq. ft. |
856 |
858 |
1,100 |
1,201 |
Clive Whiley, Chairman of Mothercare plc, commented:
“The underlying strength of the business was demonstrated by the fact that excluding the Middle East and the UK, our total retail sales on a like for like basis were positive for the full year to March 2026. However, the scheduled closure of the substantial majority of our leading Middle Eastern franchise partners’ franchised stores in the territory in 2027 has seriously undermined our core objectives. Accordingly, although Mothercare has sufficient resources to trade for a number of months, the imperative is now to prioritise discussions to conclude our strategic review of all business and pension scheme options before the year end.”
Investor and analyst enquiries to:
|
Mothercare plc Clive Whiley, Chairman Andrew Cook, Chief Financial Officer |
Email: investorrelations@mothercare.com |
|
|
|
|
|
|
|
Cavendish Capital Markets Limited (Nomad and Broker) Matt Goode
|
Tel: 020 7220 0500 |
Notes
1 – Worldwide retail sales are total international retail franchise partner sales to end customers (which are estimated and unaudited).
2 – Adjusted EBITDA, operating profit/loss and profit after taxation are stated before the impact of the adjusting items set out in note 4.
3 – Net debt is defined as total borrowings, cash at bank and IFRS 16 lease liabilities.
4 – Constant currency sales exclude the impact of movements in foreign currency exchange translation.
5 – Like-for-like (LFL) sales exclude the impact of changes to the store estate, including new store openings and closures, major store upgrades and changes to online channels. This is in addition to excluding the impact from foreign currency exchange translation.
6 – This announcement contains certain forward-looking statements concerning the Group. Although the Board believes its expectations are based on reasonable assumptions, the matters to which such statements refer may be influenced by factors that could cause actual outcomes and results to be materially different. The forward-looking statements speak only as at the date of this document and the Group does not undertake any obligation to announce any revisions to such statements, except as required by law or by any appropriate regulatory authority.
7 – The information contained within this announcement is deemed by the Company to constitute inside information for the purposes of Article 7 of the UK version of Regulation (EU) No. 596/2014 as part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended.. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.
8 – The person responsible for the release of this announcement is Lynne Medini, Group Company Secretary at Mothercare plc, Westside 1, London Road, Hemel Hempstead, HP3 9TD.
9 – Mothercare plc’s Legal Entity Identifier (“LEI”) number is 213800ZL6RPV9Z9GFO74.
As highlighted in my last Chairman’s statement, we have struggled to reverse the dis-economies of scale associated with the more than halving of our franchise partners’ store footprint over the last six years due to the pandemic, the conflict in Ukraine and the conflict and uncertainty in the Middle East. This led to the transition of the business to an asset light global franchising business to focus upon our core international franchise and brand management competencies, as evidenced more recently by new agreements in both South Asia and Turkey.
The underlying strength of the business was nonetheless demonstrated by the fact that excluding the Middle East and the UK, our total retail sales on a like for like basis were positive for the full year to March 2026. We continue to believe that there remains a greater opportunity for the brand and negotiations continue with potential new partners for the UK, and other territories where the brand is not currently present.
Subsequent Events
This time last year we believed that the closure of a net fifty stores in our Middle Eastern markets in the previous twelve months, due to the region wide reduction in footfall and therefore sales caused by the continuing regional unrest and evolving consumer behaviour had reached a conclusion. Moreover, as the majority of old inventory had been cleared the profitability of our franchise partner was improving.
The launch of the Iran war earlier this year shattered this confidence, exacerbating the challenges facing retailers in the region and culminated with the notification on 17 September by our leading Middle Eastern franchise partner that it is reviewing its Mothercare franchise stores, in the light of the ongoing situation in a number of its franchise territories. Whilst this review has yet to conclude it expects this to result in the closure of the substantial majority of the franchised stores in the territory in 2027.
Accordingly, we anticipate a material reduction in the Company’s order book for FY28 and a commensurate reduction in revenues, profits and cash flows.
As announced on 21 September 2026, the Group subsequently received £0.8 million by way of cash dividend from the administrators of Mothercare UK Limited. It was noted that whilst this is a helpful development it does not materially change the outlook for the business nor the matters disclosed in the announcement of 18 September 2026.
Trading Update
Worldwide retail sales by franchise partners of £78.1 million (H1 FY26: £90.7 million), reflect the continued uncertainty in our Middle Eastern markets, including the more recent impact of the Iran war, together with the end of our exclusive distribution relationship with Boots in the UK. The online share of retail sales for the period increased marginally to 11.9% of total retail sales (H1 FY26: 11.0%). The year-on-year decline in retail sales of 14% reduces to 12% at constant currency exchange rates. Like-for-like retail sales for the six months to September 2026 were down 3%. Excluding the Middle Eastern markets like-for-like sales increase by 2% across the period, driven mainly by the Indian and Indonesian markets.
Adjusted EBITDA for the period decreased to £0.5 million (H1 FY26: £0.8 million) leading to an adjusted loss before taxation of £2.2 million (H1 FY26: £1.1 million adjusted loss before taxation).
Net debt increased to £9.3 million at 26 September 2026 (£5.8 million at 27 September 2025) and the pension scheme deficit was £36.7 million as at 30 September 2026, which is the latest available estimate (March 2025: £35.0 million) on a technical provisions basis.
South Asian Joint Venture
In October 2024 we announced a joint venture with an entry valuation of c£30 million for the South Asian region with Reliance Brands Ltd ("Reliance"), a wholly owned subsidiary of Reliance Industries Ltd, a Fortune 500 company and the largest private sector corporation in India, which:
• underlined the inherent value of the Mothercare brand; and
• created an invigorated partnership in the South Asian region with Reliance, one of the world's largest, leading and respected business groups which will bring symbiotic and synergistic benefits.
We retain a residual 49% shareholding in the joint venture company, covering Mothercare's franchise operations in India, Nepal, Sri Lanka, Bhutan and Bangladesh, which was granted perpetual rights for the use of the Mothercare brand and related intellectual property in those regions.
Whilst we are temporarily receiving revenues at lower rates than previously, Reliance have confirmed their aspirations for the reinvigorated business to significantly grow revenue levels, and we believe it is possible for them to grow their retail sales to around £300 million in five years, supported by a store opening programme encompassing 44 new stores in 2026 and targeting approximately 50 new stores in the region in 2027. We also expect to benefit from both sourcing fees (supplying the joint venture with product) together with the value creation accruing to our residual 49% equity stake in JVCo.
License Agreement
In June 2025 we announced a license agreement for Turkey, with Ebebek Mağazacılık A.Ş. (“ebebek”), the leading retailer in our sector in Turkey meeting all the needs of mother and baby from the prenatal period up to the age of four. ebebek has some 280 stores and an online business producing revenues of around £400 million together with four stores recently opened in the UK. The license agreement gives ebebek the exclusive right to use the Mothercare brand in Turkey on products either designed and sourced by ebebek or Mothercare for a period of 10 years.
The agreement also allows Mothercare to purchase products ebebek has sourced for itself, either under its own brands or Mothercare, for sale by our franchise partners outside of the territories where ebebek trades and to re-brand these products with the Mothercare brand if relevant.
Refinancing
On 20 February 2026, we announced the successful and timely refinancing of the Group’s existing debt facilities with GB Europe Management Services Ltd ("Gordon Brothers") and the deferral of contributions to the Group’s pension schemes. The first-charge debt instrument is now owned by a consortium of our equity stakeholders, to whom we remain grateful, which is fundamental in the event of requiring further waivers to our covenant tests in the current circumstances.
Whilst this facility remains in default, and so is still repayable on demand, the Directors recognise the improved alignment between the Company’s secured creditors (including the pension and debt holders) and shareholders: which has been vindicated by recent events in the sector.
Strategic Imperative
We had intended to utilise both the new South Asian region joint venture, and recent refinancing, alongside the license agreement with ebebek (in Turkey) as a catalyst to redouble our efforts to capitalise upon the possibilities to grow the future global presence of the Mothercare brand: through connections with other businesses, the development of our branded product ranges and licensing within and beyond our existing perimeters.
These objectives were designed to rebalance the Mothercare brand IP value in a way that also promotes growth in our royalty income: ultimately improving profitability and the covenant of the underlying business for actuarial pension and stock market rating purposes alike.
The scheduled closure of the substantial majority of our leading Middle Eastern franchise partners’ franchised stores in the territory in 2027 has seriously undermined our core objectives. Accordingly, although Mothercare has sufficient resources to trade for a number of months, the imperative is now to prioritise discussions to conclude our strategic review of all business and pension scheme options before the year end.
In that context we are pursuing multiple opportunities in parallel, across a wide bandwidth of solutions, ranging from:
• the immediate appointment of replacement partners in the Middle East, which will require the goodwill of our existing franchise partner;
• negotiations with potential new partners for the UK, where we believe that there is a significantly greater opportunity, for what remains an iconic heritage brand, with a new partner in the UK;
• new partner initiatives to exploit the equivalent markets in the United States;
• expressions of interest in the IP for several of our overseas territories;
• the development of our branded product ranges via licensing within and beyond our existing perimeters; and
• engineering a more comprehensive solution to harvest the significant operational gearing retained in the business where the current business model could support much higher volumes and would result in the vast majority of increased income falling straight to the bottom line.
In addition, we are also in discussions, alongside the pension Trustee, to ensure that we consider all options to secure the pension scheme position at an optimal level for all pension, debt & equity stakeholders alike.
Pension Schemes
As previously announced, the Group’s pension Trustee has agreed to defer the payment of pension contributions due in the year to March 2027, to support the Company’s cash flows whilst we are exploring growth opportunities.
The pension deficit contributions due in the years to March 2027 and March 2026 that are deferred amount to £3.0 million in each year, a total of £6.0 million. This sum together with the remaining contributions due, will be paid in accordance with a new schedule of contributions to be put in place no later than 31 March 2027, which will include a resumption of contributions from 19 April 2027 at a level that the Trustee considers to be affordable.
Summary and Outlook
On behalf of the Board, I would once again like to thank our colleagues across the business, together with our pension trustees and all other stakeholders for their unfailing support throughout.
As detailed, we are striving to secure a sustainable business model, to ensure that Mothercare has the capacity to sponsor future growth in our franchise partners' retail sales and store footprint alongside exploring new territories and additional routes to market.
In that regard, I can assure you that the Board will leave no stone unturned to achieve that objective, notwithstanding the increasingly challenging circumstances mean the longer-term solvency of the Company remains uncertain.
Clive Whiley
Chairman
Condensed consolidated income statement
For the 26 weeks ended 26 September 2026
|
|
|
26 weeks ended 26 September 2026 (Unaudited) |
|
26 weeks ended 27 September 2025 (Unaudited)
|
52 weeks ended 28 March 2026 (Audited) | |||||
|
|
Note |
Before adjusted items £ million |
Adjusted items1
£ million |
Total
£ million |
|
Before adjusted items £ million |
Adjusted items 1
£ million |
Total
£ million |
Total
£ million | |
|
|
|
|
|
|
|
|
|
|
| |
|
Revenue |
|
9.3 |
– |
9.3 |
|
11.6 |
– |
11.6 |
22.4 | |
|
Cost of sales |
|
(5.1) |
(0.4) |
(5.5) |
|
(6.6) |
– |
(6.6) |
(12.8) | |
|
Gross profit |
|
4.2 |
(0.4) |
3.8 |
|
5.0 |
– |
5.0 |
9.6 | |
|
Share of investment in associate |
|
– |
– |
– |
|
– |
– |
– |
0.1 | |
|
Administrative expenses |
|
(4.5) |
2.6 |
(1.9) |
|
(5.3) |
(0.3) |
(5.6) |
(11.2) | |
|
Impairment gain / (loss) on receivables |
|
– |
– |
|
|
0.3 |
– |
0.3 |
0.3 | |
|
(Loss)/profit from operations |
|
(0.3) |
2.2 |
1.9 |
|
– |
(0.3) |
(0.3) |
(1.2) | |
|
Net finance costs |
5 |
(1.9) |
– |
(1.9) |
|
(1.1) |
– |
(1.1) |
(3.1) | |
|
Loss before taxation |
|
(2.2) |
2.2 |
– |
|
(1.1) |
(0.3) |
(1.4) |
(4.3) | |
|
Taxation |
6 |
(0.2) |
– |
(0.2) |
|
(0.3) |
– |
(0.3) |
(0.7) | |
|
|
|
|
|
|
|
|
|
|
| |
|
(Loss)/profit for the period |
|
(2.4) |
2.2 |
(0.2) |
|
(1.4) |
(0.3) |
(1.7) |
(5.0) | |
|
(Loss)/profit for the period attributable to equity holders of the parent |
|
(2.4) |
2.2 |
(0.2) |
|
(1.4) |
(0.3) |
(1.7) |
(5.0) | |
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
| |
|
Earnings per share |
|
|
|
|
|
|
|
|
| |
|
Basic |
7 |
(0.4)p |
|
(0.0)p |
|
(0.3)p |
|
(0.3)p |
(0.9)p | |
|
Diluted |
7 |
(0.4)p |
|
(0.0)p |
|
(0.3)p |
|
(0.3 p |
(0.9)p | |
|
|
|
|
|
|
|
|
|
|
|
|
Condensed consolidated statement of comprehensive income
For the 26 weeks ended 26 September 2026
|
|
|
26 weeks ended 26 September 2026 (Unaudited) |
26 weeks ended 27 September 2025 (Unaudited) |
52 weeks ended 28 March 2026 (Audited)
|
|
|
|
£ million |
£ million |
£ million |
|
|
|
|
|
|
|
Loss for the period |
|
(0.2) |
(1.7) |
(5.0) |
|
|
|
|
|
|
|
Items that will not be reclassified subsequently to the income statement: |
|
|
|
|
|
Actuarial gain on defined benefit pension schemes |
|
0.2 |
1.2 |
3.3 |
|
Deferred tax relating to items not reclassified |
|
– |
(0.3) |
– |
|
|
|
– |
0.9 |
3.3 |
|
Items that may be reclassified subsequently to the income statement: |
|
|
|
|
|
Exchange differences on translation of overseas subsidiaries |
|
– |
– |
– |
|
|
|
|
|
|
|
Other comprehensive income for the period |
|
– |
0.9 |
3.3 |
|
|
|
|
|
|
|
Total comprehensive (expense)/income for the period wholly attributable to equity holders of the parent |
|
– |
(0.8) |
(1.7) |
|
|
|
|
|
|
Condensed consolidated balance sheet
As at 26 September 2026
|
|
|
26 September 2026 (Unaudited) |
27 September 2025 (Unaudited) |
28 March 2026 (Audited) |
|
|
|
|
|
|
|
|
Note |
£ million |
£ million |
£ million |
|
Non-current assets |
|
|
|
|
|
Investment in associate |
8 |
10.8 |
10.8 |
10.8 |
|
Intangible assets |
9 |
6.0 |
7.3 |
6.7 |
|
Property, plant and equipment |
9 |
0.1 |
0.1 |
0.1 |
|
Right-of-use assets |
|
0.6 |
0.7 |
0.6 |
|
Deferred tax assets |
|
0.1 |
– |
0.1 |
|
|
|
17.6 |
18.9 |
18.3 |
|
Current assets |
|
|
|
|
|
Inventories |
|
0.1 |
0.3 |
– |
|
Trade and other receivables |
|
4.6 |
4.1 |
4.0 |
|
Derivative financial instruments |
12 |
|
– |
– |
|
Cash and cash equivalents |
|
2.0 |
3.0 |
2.8 |
|
|
|
6.7 |
7.4 |
6.8 |
|
|
|
|
|
|
|
Total assets |
|
24.3 |
26.3 |
25.1 |
|
|
|
|
|
|
|
Current liabilities |
|
|
|
|
|
Trade and other payables |
|
(2.3) |
(5.1) |
(5.0) |
|
Lease liabilities |
|
(0.2) |
(0.1) |
(0.2) |
|
Provisions |
|
(0.4) |
– |
(1.2) |
|
Current tax liabilities |
|
(0.1) |
(1.1) |
(0.4) |
|
Borrowings |
10 |
(10.7) |
– |
(8.5) |
|
|
|
(13.7) |
(6.3) |
(15.3) |
|
Non-current liabilities |
|
|
|
|
|
Borrowings |
10 |
– |
(8.1) |
– |
|
Lease liabilities |
|
(0.4) |
(0.6) |
(0.5) |
|
Retirement benefit obligations |
11 |
(21.0) |
(21.1) |
(20.1) |
|
Provisions |
|
(0.1) |
(0.1) |
(0.1) |
|
Deferred tax liabilities |
|
– |
(0.2) |
– |
|
|
|
(21.5) |
(30.1) |
(20.7) |
|
|
|
|
|
|
|
Total liabilities |
|
(35.2) |
(36.4) |
(36.0) |
|
|
|
|
|
|
|
Net liabilities |
|
(10.9) |
(10.1) |
(10.9) |
|
|
|
|
|
|
|
Equity attributable to equity holders of the parent |
|
|
|
|
|
Share capital |
|
89.4 |
89.3 |
89.3 |
|
Share premium account |
|
108.8 |
108.8 |
108.8 |
|
Own shares |
|
(0.2) |
(0.2) |
(0.2) |
|
Translation reserve |
|
(3.8) |
(3.8) |
(3.8) |
|
Revaluation reserve |
|
10.7 |
10.7 |
10.7 |
|
Retained deficit |
|
(215.8) |
(214.9) |
(215.7) |
|
Total equity |
|
(10.9) |
(10.1) |
(10.9) |
Condensed consolidated statement of changes in equity
For the 26 weeks ended 26 September 2026 (unaudited)
|
|
Share capital |
Share premium account |
Own shares |
Translation reserve |
Revaluation reserve |
Retained deficit |
Total equity |
|
|
£ million |
£ million |
£ million |
£ million |
£ million |
£ million |
£ million |
|
Balance as at 28 March 2026 |
89.3 |
108.8 |
(0.2) |
(3.8) |
10.7 |
(215.7) |
(10.9) |
|
Loss for the period |
– |
– |
– |
– |
– |
(0.2) |
(0.2) |
|
Other comprehensive income for the period |
– |
– |
– |
– |
– |
0.2 |
0.2 |
|
Total comprehensive expense for the period |
– |
– |
– |
– |
– |
– |
– |
|
Shares issued to settle share-based payment awards |
0.1 |
– |
– |
– |
– |
(0.1) |
– |
|
Balance at 26 September 2026 |
89.4 |
108.8 |
(0.2) |
(3.8) |
10.7 |
(215.8) |
(10.9) |
For the 26 weeks ended 27 September 2025 (unaudited)
|
|
Share capital |
Share premium account |
Own shares |
Translation reserve |
Revaluation reserve |
Retained deficit
|
Total equity
|
|
|
£ million |
£ million |
£ million |
£ million |
£ million |
£ million |
£ million |
|
Balance as at 29 March 2025 |
89.3 |
108.8 |
(0.2) |
(3.8) |
10.7 |
(214.2) |
(9.4) |
|
Loss for the period |
– |
– |
– |
– |
– |
(1.7) |
(1.7) |
|
Other comprehensive income for the period |
– |
– |
– |
– |
– |
0.9 |
0.9 |
|
Total comprehensive income for the period |
– |
– |
– |
– |
– |
(0.8) |
(0.8) |
|
Adjustments to equity for equity-settled share-based payments |
– |
– |
– |
– |
– |
0.1 |
0.1 |
|
Balance at 27 September 2025 |
89.3 |
108.8 |
(0.2) |
(3.8) |
10.7 |
(214.9) |
(10.1) |
For the 52 weeks ended 28 March 2026 (audited)
|
|
Share capital |
Share premium account |
Own shares |
Translation reserve |
Revaluation reserve |
Retained deficit |
Total equity |
|
|
£ million |
£ million |
£ million |
£ million |
£ million |
£ million |
£ million |
|
Balance at 29 March 2025 |
89.3 |
108.8 |
(0.2) |
(3.8) |
10.7 |
(214.2) |
(9.4) |
|
Loss for the year |
– |
– |
– |
– |
– |
(5.0) |
(5.0) |
|
Other comprehensive income: |
– |
– |
– |
– |
– |
– |
– |
|
Retranslation of net assets of overseas subsidiaries |
– |
– |
– |
– |
– |
– |
– |
|
Remeasurement of defined benefit schemes |
– |
– |
– |
– |
– |
3.3 |
3.3 |
|
Total other comprehensive income |
– |
– |
– |
– |
– |
3.3 |
3.3 |
|
Total comprehensive expense |
– |
– |
– |
– |
– |
(1.7) |
(1.7) |
|
Adjustment to equity for equity-settled share-based payments |
– |
– |
– |
– |
|
0.2 |
0.2 |
|
Balance at 28 March 2026 |
89.3 |
108.8 |
(0.2) |
(3.8) |
10.7 |
(215.7) |
(10.9) |
Condensed consolidated cash flow statement
For the 26 weeks ended 26 September 2026
|
|
Note |
26 weeks ended 26 September 2026 (Unaudited) |
26 weeks ended 27 September 2025 (Unaudited) |
52 weeks ended 28 March 2026 (Audited) |
|
|
|
£ million |
£ million |
£ million |
|
Net cash (outflow)/inflow from operating activities |
14 |
(2.7) |
(0.7) |
0.1 |
|
Cash flows from investing activities: |
|
|
|
|
|
Purchase of intangibles – software |
– |
(0.1) |
(0.2) | |
|
Net cash outflow from investing activities |
|
– |
(0.1) |
(0.2) |
|
Cash flows from financing activities: |
|
|
|
|
|
Repayment of borrowings |
|
– |
– |
(8.1) |
|
Drawdown of new facility |
|
1.5 |
– |
8.4 |
|
Interest paid |
|
(0.4) |
(0.4) |
(0.8) |
|
Repayments of obligations under leases |
|
(0.1) |
(0.1) |
(0.1) |
|
Dividends received from an associate |
|
0.1 |
– |
– |
|
Lease interest paid |
|
– |
– |
(0.1) |
|
Facility fee paid |
|
– |
– |
(0.1) |
|
Proceeds from post administration distribution |
|
0.8 |
– |
– |
|
Transaction costs paid on borrowings |
|
– |
– |
(0.6) |
|
Net cash inflow/(outflow) from financing activities |
|
1.8 |
(0.5) |
(1.4) |
|
|
|
|
|
|
|
Net decrease in cash and cash equivalents |
|
(0.8) |
(1.3) |
(1.5) |
|
|
|
|
|
|
|
Cash and cash equivalents at beginning of period |
|
2.8 |
4.3 |
4.3 |
|
Effect of foreign exchange rate changes |
|
– |
– |
– |
|
Cash and cash equivalents at end of period |
|
2.0 |
3.0 |
2.8 |
|
| ||||
Notes to the condensed consolidated financial statements
The review of the Group’s business activities, together with factors likely to affect its future development, performance and position are set out in the Financial Highlights and Chairman’s Statement.
The results for the 26 weeks ended 26 September 2026 are unaudited.
These unaudited condensed consolidated interim financial statements for the current period and prior financial periods do not constitute statutory accounts as defined in section 434 of the Companies Act 2006. A copy of the statutory accounts for the 2026 financial year has been filed with the Registrar of Companies. The 2026 financial statements are available on the Group’s website (www.mothercareplc.com). The auditor has reported on these: their report was unqualified.
Basis of preparation
These unaudited condensed consolidated interim financial statements have been prepared in accordance with the Disclosure and Transparency Rules of the UK Financial Conduct Authority, and with IAS 34 ‘Interim Financial Reporting’. Unless otherwise stated, the accounting policies applied, and the judgements, estimates and assumptions made in applying these policies, are consistent with those described in the Annual Report and Financial Statements 2026. The financial period represents the 26 weeks ended 26 September 2026. The comparative periods are the 26 weeks ended 27 September 2025 and the 52 weeks ended 28 March 2026.
Going concern
As stated in the Annual Report for the year ended March 2026, the Group entered into financing arrangements during the year with a consortium of investors, the majority of which are current shareholders, to refinance and vary the existing facility via a special purpose vehicle (SPV). This included extending the facility’s term to 31 December 2027. The facility is in default as a result of breaching financial covenants, which cannot be remedied, and so is repayable on demand, however, the Directors recognise the improved alignment between the Company’s secured creditors (including the pension and debt holders) and shareholders. £8.46 million was raised during the year to March 2026 with further funding of £1.54 million being raised this period via the same SPV.
The consolidated financial statements have been prepared on a going concern basis. When considering the going concern assumption, the Directors of the Group have reviewed a number of factors, including the Group’s trading results and its continued access to sufficient borrowing facilities against the Group’s latest forecasts and projections, comprising:
The Base Case forecast is based on current retail trends and, as such, includes an estimate of the impact of the closure of the substantial majority of the stores of our Middle Eastern franchise partner during 2027, which we announced in September. As the review is ongoing, and we have not had full details of the planned closures, we have included in the Base Case forecast the impact on retail sales and the mitigating changes to our business model and cost base that we will need to make.
The Sensitised forecast shows a further decrease in worldwide retail sales of 10%, as compared to the Base Case, in the remainder of the financial year to March 2027 and for the initial period of March 2028, with the overhead costs assumed to remain constant. In making the assessment on going concern the Directors have assumed that the Group is able to mitigate the material uncertainty surrounding the ongoing financial restructuring of the Group which includes:
Notes to the condensed consolidated financial statements
Going concern (continued)
The Board’s confidence in the Group’s Base Case forecast, which indicates the Group will operate with sufficient cash for at least the next 12 months, and the Group’s proven cash management capability supports our preparation of the financial statements on a going concern basis and therefore financial statements do not include the adjustments that would be required if the Group were unable to continue as a going concern.
However, if trading conditions were to deteriorate beyond the level of risks applied in the sensitised forecast, or the Group was unable to mitigate the material uncertainties assumed in the Base Case Forecast and the Group was not able to execute further cost or cash management programmes, the Group would at certain points of the working capital cycle have insufficient cash. If this scenario were to crystallise the Group would be unable to meet liabilities as they fall due and potentially need to secure additional funding. Therefore, we have concluded that, in this situation, there is a material uncertainty that casts significant doubt that the Group will be able to operate as a going concern without utilising uncommitted or new financing facilities.
Adoption of new IFRSs
The Group has applied the following amendment for the first time for its annual reporting period commencing on or after 1 January 2025:
Amendments to IAS 21 – Lack of Exchangeability
The amendment above did not have any impact on the amounts recognised in prior periods and are not expected to significantly affect the current or future periods.
Standards issued but not yet effective
IFRS 18 ‘Presentation and Disclosure in Financial Statements’
In April 2024, the IASB issued IFRS 18, ‘Presentation and Disclosure in Financial Statements’ in response to investors’ concerns about comparability and transparency of entities’ performance reporting. The new presentation requirements introduced in IFRS 18 will increase comparability of the financial performance of similar entities, especially related to how ‘operating profit or loss’ is defined. The new disclosure requirements for ‘management defined performance measures’ will enhance transparency.
IFRS 18 is effective from 1 January 2027 and has not yet been adopted by the Group. We are in the process of determining the impact of IFRS 18 on the Group. We have prepared a transition plan and are on track to report our first IFRS 18 compliant interim financial statements for the period ending 25 September 2027 and annual financial statements for the period ending 25 March 2028.
The Group currently presents an operating profit subtotal. We are performing a detailed assessment to determine the appropriate classification of items to ensure that the operating profit subtotal will comply with the requirements of IFRS 18. It is anticipated that we will reclassify income from associates from other income and interest income from finance income, however as this amount has historically not been material, we do not expect to present an investing category. The new aggregation and disaggregation requirements will lead to certain minor changes to present the most useful structured summary.
Notes to the condensed consolidated financial statements
Standards issued but not yet effective (continued)
We currently report on adjusted profit to stakeholders. It is expected that this measure will meet the definition of a management defined performance measure. The Group is performing an assessment of other measures that are currently being reported outside the financial information and whether or not these meet the definition of a management-defined performance measure. Other changes relating to amendments to IAS 7, totals and subtotals presented in the income statement, presentation of goodwill and earnings per share has no impact on the group financial statements. At each subsequent reporting period, we will provide an update on the progress towards transition to IFRS 18.
Amendments to IFRS 9 and IFRS 7 – ‘Amendments to the Classification and Measurement of Financial Instruments’
We do not expect these amendments to have any material impact on the Group financial statement as we currently do not have such
Foreign currency adjustments
Foreign currency monetary assets and liabilities are revalued to the closing balance sheet rate under IAS21 “The Effects of Changes in Foreign Exchange Rates”.
Taxation
The taxation charge for the 26 week period is calculated by applying the best estimate of the average annual effective tax rate expected for the full year to the profit/loss for the period after adjusting for any significant one-off items, and a tax credit is recognised only to the extent that the resulting tax asset is more than likely not to reverse.
Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
For defined benefit schemes, the cost of providing benefits is determined using the Projected Unit Credit Method, with actuarial valuations being carried out at each balance sheet date. Actuarial gains and losses are recognised in full in the period in which they occur. They are recognised outside of the income statement and presented in other comprehensive income.
Past service cost is recognised immediately to the extent that the benefits are already vested.
The retirement benefit obligation recognised in the balance sheet represents the present value of the defined benefit obligation less the fair value of scheme assets. Any asset resulting from this calculation is limited to past service cost, plus the present value of available refunds.
The Group has an unconditional right to a refund of surplus under the rules.
In consultation with the independent actuaries to the schemes, the valuation of the pension obligation has been updated to reflect: current market discount rates; current market values of investments and actual investment returns; and also for any other events that would significantly affect the pension liabilities. The impact of these changes in assumptions and events has been estimated in arriving at the valuation of the pension obligation.
Alternative performance measures (APMs)
In the reporting of financial information, the Directors have adopted various APMs of historical or future financial performance, position or cash flows other than those defined or specified under International Financial Reporting Standards (IFRS).
Notes to the condensed consolidated financial statements
Alternative performance measures (APMs) (continued)
These measures are not defined by IFRS and therefore may not be directly comparable with other companies’ APMs, including those in the Group’s industry.
APMs should be considered in addition to, and are not intended to be a substitute for, or superior to, IFRS measures.
Purpose
The Directors believe that these APMs assist in providing additional useful information on the performance and position of the Group because they are consistent with how business performance is reported to the Board and Operating Board.
APMs are also used to enhance the comparability of information between reporting periods and geographical units (such as like-for-like sales), by adjusting for non-recurring or uncontrollable factors which affect IFRS measures, to aid the user in understanding the Group’s performance.
Consequently, APMs are used by the Directors and management for performance analysis, planning, reporting and incentive setting purposes and have remained consistent with prior year.
The key APMs that the Group has focused on during the period are as follows:
Group worldwide sales
Group worldwide sales are total international retail franchise partner sales to end customers. Total Group revenue is a statutory number and is made up of receipts from international franchise partners, which includes royalty payments and the cost of goods dispatched to international franchise partners.
Constant currency sales
The Group reports some financial measures on both a reported and constant currency basis. Sales in constant currency exclude the impact of movements in foreign currency exchange translation.
Like-for-like (LFL) sales
Like-for-like (LFL) sales exclude the impact of changes to the store estate, including new store openings and closures, major store upgrades and changes to online channels. This is in addition to excluding the impact from foreign currency exchange translation.
Profit/(loss) before adjusted items
The Group’s policy is to exclude items that are considered to be significant in both nature and/or quantum and where treatment as an adjusted item provides stakeholders with additional useful information to assess the year-on-year trading performance of the Group.
3 Segmental information
IFRS 8 requires operating segments to be identified on the basis of internal reports about components of the Group that are regularly reported to the Group’s executive decision makers (comprising the executive directors and operating board) in order to allocate resources to the segments and assess their performance. Under IFRS 8, the Group has not identified that its continuing operations represent more than one operating segment.
The results of franchise partners are not reported separately, nor are resources allocated on a franchise partner by franchise partner basis and therefore have not been identified to constitute separate operating segments.
Notes to the condensed consolidated financial statements
4 Adjusted items
Due to their significance or one-off nature, certain items have been classified as adjusted items as follows:
|
|
26 weeks ended 26 September 2026 (Unaudited) |
26 weeks ended 27 September 2025 (Unaudited)
|
52 weeks ended 28 March 2026 (Audited) |
|
£ million |
£ million |
£ million | |
|
Adjusted items: |
|
|
|
|
Cost of sales: |
|
|
|
|
Onerous contract included in cost of sales |
(0.4) |
– |
(0.2) |
|
Administrative expenses: |
|
|
|
|
Insurance costs – defined benefit scheme buyout |
(0.1) |
– |
– |
|
Financial asset |
0.8 |
– |
– |
|
Restructuring costs included in administrative expenses |
1.9 |
(0.3) |
(0.8) |
|
|
2.6 |
– |
(0.8) |
|
Finance costs: |
|
|
|
|
Restructuring costs included in finance costs |
– |
– |
(0.7) |
|
Adjusted items before tax |
2.2 |
(0.3) |
(1.7) |
Onerous contracts – £(0.4) million (H1 FY26: £Nil)
Onerous contract costs relating to lower contracted cost recoveries compared with the actual costs incurred.
Insurance costs – defined benefit scheme buyout £(0.1) million (H1 FY26: £Nil)
This relates to a one-off insurance policy taken out in relation to the buy out of the Executive Scheme.
Financial asset – £0.8 million (H1 FY26: £Nil)
£0.8 million received from the administrator of Mothercare UK Limited which went into administration, being the true-up of the financial asset arising on the revolving capital facility.
Restructuring costs included in administrative expenses – £1.9 million (H1 FY26: (£0.3 million))
£2.0 million represents the release of certain legacy balances associated with the administration of Mothercare UK Limited. Due to their age and the assessment that no present obligation exists and that any future outflow of economic benefits is no longer probable, the liabilities were released. This is offset by £(0.1) million of costs related to restructure of the team.
The prior year costs relate to redundancy payments made to certain staff during the period.
5 Net finance costs
|
|
|
26 weeks ended 26 September 2026 (Unaudited) |
26 weeks ended 27 September 2025 (Unaudited)
|
52 weeks ended 28 March 2026 (Audited) |
|
|
|
£ million |
£ million |
£ million |
|
Interest payable and finance charges |
|
1.2 |
0.4 |
1.7 |
|
Net interest expense on liabilities/return on assets on pension |
|
0.7 |
0.7 |
1.3 |
|
Interest on lease liabilities |
|
- |
- |
0.1 |
|
Net finance costs |
|
1.9 |
1.1 |
3.1 |
Notes to the condensed consolidated financial statements
6 Taxation
|
|
|
26 weeks ended 26 September 2026 (Unaudited) |
26 weeks ended 27 September 2025 (Unaudited)
|
52 weeks ended 28 March 2026 (Audited) |
|
|
|
£ million |
£ million |
£ million |
|
Current tax – Overseas tax and UK corporation tax |
|
0.2 |
0.3 |
0.7 |
|
Deferred tax – UK tax charge for temporary differences |
|
– |
– |
– |
|
Total tax charge |
|
0.2 |
0.3 |
0.7 |
In addition to the amount charged to the income statement, deferred tax charge relating to retirement benefit obligations amounting to £Nil has been charged directly to other comprehensive income (H1 FY26: £0.3 million).
7 (Loss)/earnings per share
|
|
|
26 weeks ended 26 September 2026 (Unaudited) |
26 weeks ended 27 September 2025 (Unaudited)
|
52 weeks ended 28 March 2026 (Audited) | |
|
|
|
million |
million |
million | |
|
Weighted average number of shares in issue for the purpose of basic earnings per share |
|
564.7 |
563.8 |
563.8 | |
|
Dilutive potential ordinary shares |
|
– |
– |
– | |
|
Weighted average number of shares in issue for the purpose of diluted earnings per share |
|
564.7 |
563.8 |
563.8 | |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
£ million |
£ million |
£ million | |
|
Loss for basic and diluted earnings per share |
|
(0.2) |
(1.7) |
(5.0) | |
|
Adjusted items |
|
2.2 |
0.3 |
(1.7) | |
|
Tax effect of adjusted items |
|
– |
– |
– | |
|
Adjusted loss |
|
(2.4) |
(1.4) |
(3.3) | |
|
|
|
|
|
| |
|
|
|
Pence |
Pence |
Pence | |
|
Basic losses per share |
|
(0.0) |
(0.3) |
(0.9) | |
|
Basic adjusted losses per share |
|
(0.4) |
(0.3) |
(0.6) | |
|
Diluted losses per share |
|
(0.0) |
(0.3) |
(0.9) | |
|
Diluted adjusted losses per share |
|
(0.4) |
(0.3) |
(0.6) | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The total dividend for the period is nil pence per share (H1 FY26: nil pence per share).
Where there is a loss per share, the calculation has been based on the weighted average number of shares in issue, as the loss renders all potentially dilutive shares anti-dilutive.
8 Investment in associate
JVCO 2024 Ltd is engaged in retailing of clothing, equipment and other categories for parents and young children via a franchisee model in the territories of India, Bhutan, Sri Lanka, Nepal and Bangladesh.
At year end, the associate did not hold any contingent liabilities or commitments.
Notes to the condensed consolidated financial statements
The tables below provide summarised financial information for JVCO 2024 Ltd. The information disclosed reflects the amounts presented in the financial statements of JVCO 2024 Ltd and not Mothercare Plc’s share of those amounts.
|
Summarised Statement of Financial position |
£ million |
|
Intangible assets |
33.3 |
|
Trade and other receivables |
0.2 |
|
Cash and cash equivalents |
0.1 |
|
Total assets |
33.6 |
|
Net assets |
33.6 |
|
|
|
|
Reconciliation to carrying amounts |
£ million |
|
Opening net assets at 28 March 2026 |
10.8 |
|
Profit for the period |
– |
|
Closing net assets |
10.8 |
|
Group’s share in % |
49% |
|
Groups share in £million |
10.8 |
|
Carrying amount |
10.8 |
9 Tangible fixed assets and Software assets
There were no additions to Right-of-use assets in the period.
Capital additions of £Nil were made during the period (H1 FY26: £0.1 million). These are software assets of £Nil (H1 FY26: £0.1 million).
10 Borrowings
The carrying value of the Group’s outstanding borrowings at 26 September 2026 was £10.7 million (28 March 2026: £8.5 million). The Group is required to achieve certain royalty, EBITDA and minimum liquidity targets under its loan’s covenants. Subsequent to the year end and prior to the interim reporting date, the Group received an additional £1.54 million advance under the existing CTM Funding Limited facility, increasing the total facility drawn to £10.0 million. The additional funding was provided under the existing terms and conditions of the facility, including the maturity date of 31 December 2027, coupon structure and covenant requirements.
CTM Funding Limited holds a fixed and floating charge over all property or undertaking of a subsidiary of the Group. The Group is in breach of the loan covenants as at the reporting date and accordingly, the loan is repayable on demand and as a result the outstanding balance has been classified as a current liability.
11 Retirement benefit schemes
At the beginning of period, the Group operated two defined benefit pension schemes, the Executive Scheme and the Staff Scheme. During the period, the buy-out of the Executive scheme was completed with the scheme’s obligations transferred to an insurance company. Following completion of the transaction, the Group was discharged from its obligation in respect of the benefits covered by the buy-out. The transaction constituted a settlement and resulted in no settlement gain or loss.
Following the buy-out, the Group has only the Staff Scheme remaining. At the interim date, the net defined benefit liability in respect of the Staff Scheme was £21.0 million.
The measurement of the remaining schemes defined benefit obligation was based on the FY26 year-end assumptions rolled forward and updated for changes in market rates over the current interim period. This resulted in an actuarial gain of £0.2 million. (H1 FY26: £1.2 million)
Notes to the condensed consolidated financial statements
12 Financial instruments: fair value disclosures
The Group held the following financial instruments at fair value at 26 September 2026.
|
|
|
Fair value measurements at 26 September 2026 (Unaudited) |
Fair value measurements at 27 September 2025 (Unaudited) |
Fair value measurements at 28 March 2026 (Audited) |
|
|
|
£ million |
£ million |
£ million |
|
Current financial assets: |
|
|
|
|
|
Derivative financial instruments: |
|
|
|
|
|
Financial asset |
|
– |
– |
– |
|
|
|
– |
– |
– |
|
|
|
|
|
|
The Group’s financial asset (Level 3 within the IFRS 7 hierarchy) represents a right, arising under the sales purchase agreement with the administrators of MUK, to receive the proceeds of the wind-up of the UK retail store estate and website operations as repayment for the Group’s secured borrowings. Many of the outflows which would impact the valuation of this financial asset are finalised, with the final repayment being dependent on the amounts to be received back by the merchant acquirer and final settlement of VAT. At the end of the period no further proceeds was expected however during the year an amount of £0.8 million was received from the administrators.
The Directors consider that the carrying value amounts of financial assets and financial liabilities recorded at amortised cost in the financial statements are approximately equal to their fair values.
13 Share-based payments
A charge is recognised for share-based payments based on the fair value of the awards at the date of grant, the estimated number of shares that will vest and the vesting period of each award. The total net charge for share-based payments under IFRS 2 is £Nil (H1 FY26: £0.1 million).
14 Notes to the cash flow statement
|
|
26 weeks ended 26 September 2026 (Unaudited) |
26 weeks ended 27 September 2025 (Unaudited)
|
52 weeks ended 28 March 2026 (Audited) |
|
|
£ million |
£ million |
£ million |
|
Profit / (loss) from operations |
1.9 |
(0.3) |
(1.2) |
|
Adjustments for: |
|
|
|
|
Depreciation of property, plant and equipment and right of use assets |
0.1 |
0.1 |
0.3 |
|
Amortisation of intangible assets |
0.7 |
0.7 |
1.3 |
|
Share of profit in associate |
– |
– |
(0.1) |
|
Gain on foreign currency adjustments |
– |
– |
(0.2) |
|
Share-based payments |
– |
0.1 |
0.2 |
|
Movement in legacy balances |
(2.0) |
– |
– |
|
Movement in provisions |
– |
(0.5) |
(0.2) |
|
Net gain on financial derivative instruments |
(0.8) |
– |
– |
|
Payments to retirement benefit schemes |
– |
(0.2) |
(0.3) |
|
Charge in respect of retirement benefit schemes |
0.4 |
0.6 |
1.3 |
|
Operating cash (outflow)/inflow before movement in working capital |
0.3 |
0.5 |
1.1 |
|
Decrease/(increase) in inventories |
(0.1) |
0.3 |
0.6 |
|
Decrease/(increase) in receivables |
(0.2) |
(0.4) |
0.1 |
|
Increase/(decrease) in payables |
(1.4) |
(0.7) |
(1.1) |
|
Cash (used in) / generated from operations |
(1.4) |
(0.3) |
0.7 |
|
Income taxes paid |
(1.3) |
(0.4) |
(0.6) |
|
Net cash (outflow) / inflow from operating activities after tax |
(2.7) |
(0.7) |
0.1 |
|
| |||
Notes to the condensed consolidated financial statements
Analysis of net debt
|
|
28 March 2026 |
Cash flow |
Non–cash movements |
26 September 2026 |
|
|
£ million |
£ million |
£ million |
£ million |
|
Cash and cash equivalents |
2.8 |
(0.8) |
– |
2.0 |
|
IFRS 16 lease liabilities |
(0.7) |
0.1 |
– |
(0.6) |
|
Term loan |
(8.5) |
(1.5) |
(0.7) |
(10.7) |
|
Net debt |
(6.4) |
(2.2) |
(0.7) |
(9.3) |
|
|
|
|
|
|
15 Related party transactions
During the period, the Group entered into an additional advance of £1.5 million under the existing financing arrangements with CTM Funding Limited. As the SPV is majority owned by Mr Richard Griffiths, a substantial shareholder of the Company, the additional advance constitutes a related party transaction. The Board, having consulted with its nominated adviser at that time, considered the terms of the additional funding to be fair and reasonable insofar as the Company's shareholders are concerned.
During the six-month period, the facility was increased by a further £1.5 million, bringing the total principal funding advanced under the facility to £10.0 million, which represents the maximum facility amount available under the financing arrangements. The facility continues to mature on 31 December 2027 and bears interest at a total rate of 25% per annum, comprising a 10% per annum cash coupon payable monthly and a 15% per annum payment-in-kind ("PIK") coupon, which is capitalised and added to the outstanding principal balance.
At 26 September 2026, the outstanding balance attributable to the SPV was £10.7 million (28 March 2026: £8.5 million), including accrued and capitalised PIK interest of £0.7 million (28 March 2026: £0.1 million). During the period, the Group recognised finance costs of £1.1 million in respect of the facility, comprising cash interest expense of £0.4 million and PIK interest expense of £0.7 million.
The facility remains subject to existing events of default and is therefore contractually repayable on demand. Accordingly, the related borrowing continues to be classified in accordance with the requirements of IAS 1 based on the rights and obligations existing at the reporting date.
No guarantees were provided to or received from related parties in connection with the facility other than the security arrangements applicable to all lenders participating in the financing. There were no other related party transactions with Mr Griffiths or his associated undertakings during the period requiring disclosure.
Transactions between the Company and its subsidiaries, which are related parties, have been eliminated on consolidation and are not disclosed in this note.
Additional Disclosures
Risk management framework
A risk management framework is in place which is appropriate for the size and complexity of the business with consideration to its AIM listing, future partner and system developments and Brand promotion and evolution.
MGB maintains its risk management function in line with the Quoted Companies Alliance Corporate Governance Code (QCA Code) complying with AIM Rule 26. The Audit & Risk Committee provides oversight, as to the overall suitability and effectiveness of the risk management approach and is accountable and supported by the Board. The Operating Board formally reviews, discusses and documents the Principal Risks to the business at least annually. The Risk Committee, which is chaired by the CFO, sits quarterly to understand existing and developing issues, and MGB Senior Managers contribute to and update Operational Risk registers, as a minimum also quarterly. All colleagues recognise their responsibility to proactively identify and manage risk and opportunity in their daily activities and planning.
Principal risks and uncertainties
Reviewed, discussed and agreed by the Operating Board annually, MGB Principal Risks are designed to promote strategic success and improve future performance, the impact of operational risks on these determines the focus for senior management and their teams. The following risks have been agreed:
Directors’ Responsibility statement
The Directors are responsible for preparing the Interim Results for the 26-week period ended 26 September 2026 in accordance with applicable law, regulations and accounting standards. The Directors confirm that to the best of their knowledge the condensed consolidated interim financial statements have been prepared in accordance with IAS 34: ‘Interim Financial Reporting’, and that the interim management report includes a fair review of the information required by DTR 4.2.7R and DTR 4.2.8R, namely:
The Directors of Mothercare plc are listed on page 22 of the Mothercare plc Annual Report and Financial Statements 2026. A list of directors is maintained on the Mothercare plc website at: www.mothercareplc.com. With the exception of today’s announcement, there have been no changes since the publication of the Annual Report.
By order of the Board
Clive Whiley Andrew Cook
Chairman Chief Financial Officer
20 November 2026
Shareholder information
Financial calendar
|
|
2027 |
|
|
|
|
Preliminary announcement of results for the 52 weeks ending 27 March 2027 |
August |
|
Issue of report and accounts |
August |
|
Annual General Meeting |
September |
|
Announcement of interim results for the 26 weeks ending 25 September 2027 |
November |
Registered office and head office
Westside 1, London Road, Hemel Hempstead, Hertfordshire HP3 9TD
www.mothercareplc.com
Registered number 1950509
Group Company Secretary
Lynne Medini
Registrars
Administrative enquiries concerning shareholders in Mothercare plc for such matters as the loss of a share certificate, dividend payments or a change of address should be directed, in the first instance, to the registrars:
Equiniti Limited
Highdown House,
Yeoman Way,
Worthing,
West Sussex,
BN99 6DA
Telephone 0371 384 2013
www.shareview.co.uk